Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Apogee Therapeutics Inc’s stock clocked out at $44.32, up 0.14% from its previous closing price of $44.26. In other words, the price has increased by $0.14 from its previous closing price. On the day, 1.45 million shares were traded. APGE stock price reached its highest trading level at $46.62 during the session, while it also had its lowest trading level at $43.48.
Ratios:
To gain a deeper understanding of APGE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $95.
On November 25, 2024, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $89.
On May 10, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $80.BofA Securities initiated its Buy rating on May 10, 2024, with a $80 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 02 ’25 when CARL DAMBKOWSKI bought 22,345 shares for $44.26 per share.
Dambkowski Carl sold 2,725 shares of APGE for $100,716 on Jun 04 ’25. The Chief Medical Officer now owns 241,723 shares after completing the transaction at $36.96 per share. On May 07 ’25, another insider, Dambkowski Carl, who serves as the Chief Medical Officer of the company, sold 2,725 shares for $35.75 each. As a result, the insider received 97,419 and left with 244,448 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APGE now has a Market Capitalization of 2584418816 and an Enterprise Value of 2033445504.
Stock Price History:
The Beta on a monthly basis for APGE is 1.49, which has changed by 0.16570222 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, APGE has reached a high of $63.50, while it has fallen to a 52-week low of $26.20. The 50-Day Moving Average of the stock is 11.49%, while the 200-Day Moving Average is calculated to be 1.89%.
Shares Statistics:
It appears that APGE traded 738.15K shares on average per day over the past three months and 859440 shares per day over the past ten days. A total of 46.04M shares are outstanding, with a floating share count of 37.32M. Insiders hold about 37.32% of the company’s shares, while institutions hold 88.24% stake in the company. Shares short for APGE as of 1749772800 were 9175746 with a Short Ratio of 12.43, compared to 1747267200 on 10209991. Therefore, it implies a Short% of Shares Outstanding of 9175746 and a Short% of Float of 33.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
